Long-term fracture risk among women with proven endometriosis
Observational
OA: closed
CC0
⤵ 6 in-corpus citations
AI-generated summary
This study investigated the long-term risk of fractures in women diagnosed with endometriosis, comparing it to women without the condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To determine whether women with pelvic endometriosis are at increased fracture risk.
DESIGN: Historical cohort study.
SETTING: Population-based investigation using the data resources of the Rochester Epidemiology Project.
PATIENT(S): From Olmsted County, Minnesota, 987 women with endometriosis that was first surgically visualized or histologically proven in 1970-1989.
INTERVENTION(S): None, observational study.
MAIN OUTCOME MEASURE(S): Follow-up for fractures through complete inpatient and outpatient community medical records.
RESULT(S): In 17,408 person-years of follow-up, 256 women experienced 449 different fractures. The cumulative incidence after 20 years (30.8%) was not elevated relative to that expected (30.6%). The independent predictors of any fracture included age (hazard ratio [HR] per 10 years: 1.61; 95% confidence interval [CI] 1.42-1.84]), corticosteroid use (HR: 2.78; 95% CI 1.48-5.24), prior hip, spine, or forearm fracture (HR: 1.82; 95% CI 1.10-3.02), and use of the selective estrogen receptor modulators, tamoxifen or raloxifene (HR: 4.34; 95% CI 2.14-8.81); physical activity was protective (HR: 0.40; 95% CI 0.18-0.88). There was no significant influence on fracture risk of surgery or other medical treatments for endometriosis.
CONCLUSION(S): Despite reported adverse effects of treatment on bone density, there was no overall increase in long-term fracture risk in this unselected cohort of women with proven endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (61)
- Add-back therapy and gonadotropin-releasing hormone agonists in the treatment of patients with endometriosis: can a consensus be reached? Add-Back Consensus Working Group via openalex
- Bone density in women with endometriosis via openalex
- Bone mass in endometriosis patients treated with GnRH agonist implant or danazol via openalex
- Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol via openalex
- Evidence that the loss of bone mass induced by GnRH agonists is not totally recovered via openalex
- Gonadotrophin - releasing hormone analogues for endometriosis: bone mineral density via openalex
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex
- Incidence of pelvic endometriosis in Rochester, Minnesota, 1970-1979 via openalex
- Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up via openalex
- Nafarelin therapy in endometriosis: long-term effects on bone mineral density via openalex
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up via openalex
- Reduced bone mass in reproductive-aged women with endometriosis via openalex
- Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration via openalex
- Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment via openalex
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment via openalex
- The epidemiology of endometriosis via openalex
- The impact of bone loss in women with endometriosis via openalex
- Total and regional bone mass values and biochemical markers of bone remodeling in endometriosis via openalex
- Women of reproductive age with endometriosis are not osteopenic via openalex
- W2065224313 via openalex
- W2090185696 via openalex
- W2093089036 via openalex
- W2108063837 via openalex
- W2124011858 via openalex
- W2126070576 via openalex
- W2137393443 via openalex
- W2160287478 via openalex
- W2212831907 via openalex
- W2242810181 via openalex
- W2287757320 via openalex
- W2324682309 via openalex
- W2398742257 via openalex
- W2407686213 via openalex
- W2796700885 via openalex
- W88676188 via openalex
- W6655287665 via openalex
- W6672127118 via openalex
- W6688044186 via openalex
- W6714902491 via openalex
- W6717193529 via openalex
- W4293241248 via openalex
- W142500578 via openalex
- W1570622790 via openalex
- W1963947891 via openalex
- W1966813919 via openalex
- W1967446803 via openalex
- W1971909806 via openalex
- W1977365834 via openalex
- W1979300931 via openalex
- W1986238913 via openalex
- W1993192474 via openalex
- W1997258883 via openalex
- W1999996730 via openalex
- W2007225257 via openalex
- W2033401946 via openalex
- W2034500438 via openalex
- W2039901604 via openalex
- W2040717245 via openalex
- W2050587934 via openalex
- W2051862321 via openalex
Cited by (7)
- Endometriosis-associated bone loss: re-evaluating the potential role of systemic inflammation and hypoestrogenic therapies 2026
- Endometriosis and menopausal health: An EMAS clinical guide 2025
- Relationship between bone mineral density and ovarian function and thyroid function in perimenopausal women with endometriosis: a prospective study 2022
- Relationship Between Bone Mineral Density and Ovarian Function in Perimenopausal Women With Endometriosis: A Prospective Study 2021
- Bone mineral density in women with deep infiltrating endometriosis who have undergone early bilateral oophorectomy 2020
- Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation 2015
- Long-term fracture risk among women with proven endometriosis 2008
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:04:05.892929+00:00
- unpaywall
- last seen: 2026-09-17T06:32:46.214484+00:00
License: CC0
· commercial use OK